{"_id": "650139dafddc0bb1312fb031", "Not yet fixed MQL": "{\n\"and\": [\n{\n\"$and\": [\n{\"cancer type\": \"melanoma\"},\n{\"metastasis to brain\": true}\n]\n},\n{\n\"$and\": [\n{\"primary tumor origin\": {\"$in\": [\"cutaneous\", \"acral/mucosal\", \"unknown\"]}},\n{\"primary tumor origin\": {\"$ne\": \"uveal\"}}\n]\n},\n{\"BRAF-V600 mutation\": true},\n{\n\"$and\": [\n{\"days since brain MRI\": {\"$lt\": 28}},\n{\"brain metastasis size\": {\"$gte\": 0.5}},\n{\"brain metastasis size\": {\"$ne\": \"irradiated\"}},\n{\"brain metastasis size\": {\"$ne\": \"progressed\"}},\n{\"MRI slice thickness\": {\"$lte\": 1.5}},\n{\"CT of head\": false},\n{\"CNS disease documented\": true}\n]\n},\n{\"extracranial disease\": true},\n{\"disease assessment documented\": true},\n{\"leptomeningeal disease\": true},\n{\"corticosteroids dose\": {\"$lte\": 8}},\n{\"Zubrod performance status\": {\"$lte\": 2}},\n{\"days since history and physical examination\": {\"$lt\": 28}},\n{\"able to swallow and retain pills\": true},\n{\"Hemoglobin\": {\"$gte\": 8}},\n{\"Absolute neutrophil count\": {\"$gte\": 1500}},\n{\"Platelets\": {\"$gte\": 75000}},\n{\"Total bilirubin\": {\"$lte\": 1.5}},\n{\"AST and ALT\": {\"$lte\": 2.5}},\n{\"Creatinine\": {\"$lte\": 2}},\n{\"cardiac risk assessment\": {\"$in\": [\"2B\", \"better\"]}},\n{\"prior or concurrent malignancy\": true},\n{\"HIV infection status\": {\"$ne\": \"positive\"}},\n{\"HCV infection status\": {\"$ne\": \"positive\"}},\n{\"image banking\": true},\n{\"specimen and blood collections\": true},\n{\"informed consent\": true},\n{\"institutional review board approval\": {\"$gte\": 365}}\n]\n},\n{\n\"$not\": {\n\"$or\": [\n{\"prior systemic therapy for metastatic disease\": true},\n{\"days since prior radiation therapy\": {\"$lt\": 7}},\n{\"additional systemic anti-tumor therapy\": true},\n{\"use of hormonal contraceptives\": true},\n{\"serious active infection\": true},\n{\"active autoimmune disease\": true},\n{\"immune-related adverse events\": true},\n{\"adverse events related to encorafenib and/or binimetinib\": true},\n{\"pregnant or nursing\": true}\n]\n}\n}\n]\n}", "nctId": "NCT04511013", "title": "A Randomized Phase 2 Trial of Encorafenib + Binimetinib + Nivolumab vs Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases"}